EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Escherichia coli Nissle 1917 as a Programmable Bridge Chassis for Biomanufacturing and Host‐Responsive Living Systems

Xin-Yan Lu, Xin-Yue Fang, Yu-Han Liu, Jun-Yi Cao iD, Xiao-Fan Ao, Ling-Man Wang, Mian Li, Xue Cai iD, Zhi-Qiang Liu iD, Yu-Guo Zheng iD

Advanced Science · 15.11.2026

DOI: 10.1002/advs.78440 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 15.11.2026. Verfasst von Xin-Yan Lu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Huadong Industry Technology Institute of Synthetic Biology, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou,…. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Huadong Medicine Joint Fund of the Zhejiang Provincial Natural Science Foundation of China, Central Guidance on Local Science and Technology Development Fund of Zhejiang Province, Zhejiang Provincial College Students' Science and Technology Innovation Activity Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microbial biomanufacturing and engineered probiotics increasingly use related microbial lineages across distinct product architectures, but the associated engineering and evidence requirements are rarely compared. Here, Escherichia coli Nissle 1917 (EcN) is evaluated as a programmable bridge chassis across four alternative deployment modes: purified molecule, cell‐derived architecture/material, living‐cell product, and host‐state‐responsive living system. The review links carbon–nitrogen–energy–redox allocation and global regulation to cellular‐state trajectories, interface capacity, safety refactoring, materials‐assisted protection, containment, and mode‐specific qualification. Direct evidence includes 100‐L heparosan fermentation, antibiotic‐free β‐alanine production, engineered outer‐membrane‐vesicle delivery, human studies of phenylalanine‐consuming EcN, and glucose‐responsive GLP‐1 delivery in diabetic mice and non‐human primates. The terminated SYNB1934 Phase 3 program is considered alongside positive studies to distinguish proof of function, pharmacodynamic activity, tolerability, manufacturing readiness, and late‐stage efficacy. Operational criteria for bridge‐chassis designation, explicit rules for boundary cases, and a prospective design–build–test–learn agenda are proposed. As functional embodiment changes, engineering priorities shift among flux, state, interface, formulation, containment, and evidence—not necessarily toward a more advanced mode.

Schlagwörter

Stichwörter der Autor:innen

Escherichia coli Nissle 1917interface engineeringliving therapeuticsmicrobial biomanufacturingprogrammable bridge chassissynthetic biology

Autor:innen und Institutionen

  • Huadong Industry Technology Institute of Synthetic Biology, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, People's Republic of China.
  • State Key Laboratory of Green Chemical Synthesis and Conversion, Zhejiang University of Technology, Hangzhou, People's Republic of China.
  • Zhejiang Key Laboratory of Functional Structural Lipid Synthesis and Application, Hangzhou, People's Republic of China.
  • National and Local Joint Engineering Research Center for Biomanufacturing of Chiral Chemicals, Zhejiang University of Technology, Hangzhou, People's Republic of China.

ORCID-Profile: Jun-Yi Cao, Xue Cai, Zhi-Qiang Liu, Yu-Guo Zheng

Förderung

  • Huadong Medicine Joint Fund of the Zhejiang Provincial Natural Science Foundation of China
  • Central Guidance on Local Science and Technology Development Fund of Zhejiang Province
  • Zhejiang Provincial College Students' Science and Technology Innovation Activity Program
  • Zhejiang University of Technology College Students' Innovation Training Program

Zitieren

APA

Lu, X. Y., Fang, X. Y., Liu, Y. H., Cao, J. Y., Ao, X. F., Wang, L. M., Li, M., Cai, X., Liu, Z. Q., & Zheng, Y. G. (2026). Escherichia coli Nissle 1917 as a Programmable Bridge Chassis for Biomanufacturing and Host‐Responsive Living Systems. Advanced Science. https://doi.org/10.1002/advs.78440

Vancouver

Lu XY, Fang XY, Liu YH, Cao JY, Ao XF, Wang LM, et al. Escherichia coli Nissle 1917 as a Programmable Bridge Chassis for Biomanufacturing and Host‐Responsive Living Systems. Advanced Science. 2026. doi:10.1002/advs.78440

BibTeX
@article{Lu2026,
  author = {Lu, Xin-Yan and Fang, Xin-Yue and Liu, Yu-Han and Cao, Jun-Yi and Ao, Xiao-Fan and Wang, Ling-Man and Li, Mian and Cai, Xue and Liu, Zhi-Qiang and Zheng, Yu-Guo},
  title = {Escherichia coli Nissle 1917 as a Programmable Bridge Chassis for Biomanufacturing and Host‐Responsive Living Systems},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.78440}
}
Kostenlos starten →